Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA262290
Max Phase: Preclinical
Molecular Formula: C51H70N16O11S2
Molecular Weight: 1147.36
Molecule Type: Protein
Associated Items:
ID: ALA262290
Max Phase: Preclinical
Molecular Formula: C51H70N16O11S2
Molecular Weight: 1147.36
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@H](CCC(=O)O)NC1=O
Standard InChI: InChI=1S/C51H70N16O11S2/c1-28(68)60-40-25-79-80-26-41(50(78)61-34(43(53)71)14-7-8-18-52)67-47(75)38(21-30-23-58-33-13-6-5-12-32(30)33)65-44(72)35(15-9-19-57-51(54)55)62-46(74)37(20-29-10-3-2-4-11-29)64-48(76)39(22-31-24-56-27-59-31)66-45(73)36(63-49(40)77)16-17-42(69)70/h2-6,10-13,23-24,27,34-41,58H,7-9,14-22,25-26,52H2,1H3,(H2,53,71)(H,56,59)(H,60,68)(H,61,78)(H,62,74)(H,63,77)(H,64,76)(H,65,72)(H,66,73)(H,67,75)(H,69,70)(H4,54,55,57)/t34-,35+,36-,37-,38-,39+,40-,41-/m0/s1
Standard InChI Key: CRCUBANWRKRAPH-MRNBJYARSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1147.36 | Molecular Weight (Monoisotopic): 1146.4851 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Cody WL, Wilkes BC, Muska BJ, Hruby VJ, Castrucci AM, Hadley ME.. (1984) Cyclic melanotropins. 5. Importance of the C-terminal tripeptide (Lys-Pro-Val)., 27 (9): [PMID:6332195] [10.1021/jm00375a018] |
Source(1):